Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Acute respiratory distress syndrome (ARDS) is a life-threatening condition with a high mortality. Currently, there are no proven pharmacological therapies available for the management of ARDS patients. Mesenchymal Stem Cells (MSCs) have been shown to be interesting candidates for treating ARDS. But their therapeutic effects as demonstrated in animal models and clinical trials have been inconsistent. The observations that MSC treatment may result in unwanted effects under certain conditions suggest a need for identifying biomarkers in ARDS patients to guide MSC therapy. This project seeks to investigate whether the lung microenvironment plays an important role in determining MSC function in ARDS. Plasma will be collected from ARDS patients and divided into 2 groups. TO BE CONT’D
Haibo Zhang
Guangzhou Medical University
Life Sciences
Health and Related Sciences & Technology; Life Sciences (not health)
University of Toronto
Globalink Research Award
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.